Skip to main content
. 2021 Sep 9;8:716840. doi: 10.3389/fmed.2021.716840

Table 2.

Laboratory findings of the study population.

Hyperuricemia(n =72) Normuricemia(n =177) P-value
Uric acid, μmol/L 489.17 ± 99.25 296.84 ± 72.33 <0.001
Tn-T (ng/mL) 0.48 ± 1.27 0.50 ± 1.06 0.895
CK-MB (ng/mL) 23.96 ± 67.02 17.94 ± 34.77 0.354
Myoglobin (ng/ml) 211.57 ± 411.52 113.59 ± 190.81 0.011
NTproBNP (pg/mL) 3,796.49 ± 6,378.48 1,576.58 ± 3,773.46 0.001
TC (mmol/L) 4.33 ± 1.25 4.22 ± 0.99 0.462
TG (mmol/L) 1.73 ± 1.21 1.35 ± 0.71 0.004
HDL-C (mmol/L) 1.02 ± 0.49 1.05 ± 0.49 0.657
LDL-C (mmol/L) 2.47 ± 1.06 2.47 ± 0.87 0.977

CK-MB, creatine kinase-isoenzyme; Tn-T, troponin T; NTproBNP, N-terminal-pro-brain natriuretic peptide; TC, total cholesterol; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol.